Lipoprotein(a), atherosclerosis and cardiovascular risk
At the end of the 20th century, the contribution of hyperlipoproteinemia (a) to early development and severity of coronary, cerebral and peripheral artery atherosclerosis was established, and its association with the development of aortic valve stenosis was shown. The results of epidemiological stud...
Saved in:
| Main Authors: | E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2024-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/3080 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of lipoprotein(a) variability in clinical practice and their impact on cardiovascular risk
by: Hyung Joon Joo, et al.
Published: (2025-07-01) -
Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01) -
Subclinical atherosclerosis as a risk factor of cardiovascular events
by: S. A. Boytsov, et al.
Published: (2012-06-01) -
Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice
by: A. I. Sapina, et al.
Published: (2025-01-01) -
EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)